ReviewVaccines2020
Cholera, the Current Status of Cholera Vaccines and Recommendations for Travellers.
Review in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Environmental regulation of virulence in Vibrio cholerae: integrating multi-omics, predictive models, and comparative insights across emerging Vibrio species.Gut pathogens · 2026Review
- Epidemiology and clinical profile of diarrhea associated with enterotoxigenic Escherichia coli and Vibrio cholerae in Bangladesh: Findings from a hospital-based surveillance system, 2008-2023.PLoS neglected tropical diseases · 2025Article
- Plant-based edible vaccines: Can cholera be the case study in Africa?Journal, genetic engineering & biotechnology · 2025Review
- Knowledge, attitudes, and self-reported practices regarding cholera among six MENA countries following cholera outbreaks in the region.BMC public health · 2025Article
- Cholera outbreaks: Public health implications, economic burden, and preventive strategies.AIMS public health · 2025Review
- Satellite-Derived, Smartphone-Delivered Geospatial Cholera Risk Information for Vulnerable Populations.GeoHealth · 2024Article
- Cholera rages in Africa and the Middle East: A narrative review on challenges and solutions.Health science reports · 2024Review
- Cholera vaccine clinical trials: A cross-sectional analysis of clinical trials registries.Human vaccines & immunotherapeutics · 2023Article
- The cholera challenge: How should the world respond?New microbes and new infections · 2023Article
- Review
- Knowledge, Attitude, and Practice in a Sample of the Lebanese Population Regarding Cholera.International journal of environmental research and public health · 2022Article
- Virus-like Particle Display ofACS infectious diseases · 2022Article
- Threats and outbreaks of cholera in Africa amidst COVID-19 pandemic: a double burden on Africa's health systems.Tropical medicine and health · 2021Article
- CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe.Scientific reports · 2021Article
- Travel vaccines throughout history.Travel medicine and infectious diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cholera is endemic in approximately 50 countries, primarily in Africa and South and Southeast Asia, and in these areas, it remains a disease associated with poverty. In developed nations, cholera is rare, and cases are typically imported from endemic areas by returning travellers. Cholera is readily preventable with the tools available to modern medicine. In developing nations, cholera transmission can be prevented through improved water, sanitation, and hygiene services and the use of oral cholera vaccines (OCVs). For travellers, risk can be mitigated by practicing regular hand hygiene and consuming food and water from safe sources. OCVs should be considered for high-risk travellers likely to be exposed to cholera patients or contaminated water and food. There are currently three World Health Organization pre-qualified OCVs, which are based on killed whole-cell strains of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.